Transgene Biotek Limited (BOM:526139)

Transgene Biotek Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	228	150	254	617	189	274
Market Cap Growth	-33.85%	-40.90%	-58.85%	226.91%	-31.03%	-21.18%
Enterprise Value	399	314	393	752	314	390
Last Close Price	3.01	1.98	3.35	8.14	2.49	3.61
PS Ratio	107.99	71.03	97.37	262.57	342.41	315.51
PB Ratio	2.72	1.79	2.53	5.76	1.66	1.57
P/TBV Ratio	12.40	8.16	7.28	14.82	3.92	4.59
P/FCF Ratio	-	-	-	13408.00	-	279.68
P/OCF Ratio	-	-	21.23	13408.00	94333.65	279.68
EV/Sales Ratio	188.84	148.89	150.87	320.27	569.87	449.30
EV/FCF Ratio	-	-	-	16354.75	-	398.27
Debt / Equity Ratio	2.05	2.05	1.45	1.31	1.15	0.69
Debt / FCF Ratio	-	-	-	3043.70	-	122.78
Net Debt / Equity Ratio	2.04	2.04	1.42	1.31	1.15	0.69
Net Debt / EBITDA Ratio	-31.42	-31.42	-12.68	-23.09	-12.45	-26.01
Net Debt / FCF Ratio	-1511.15	-1511.15	-28.26	3042.02	-10084.15	122.62
Asset Turnover	0.00	0.00	0.00	0.00	0	0.00
Inventory Turnover	-	-	-	0.09	1.03	-
Quick Ratio	0.01	0.01	0.02	0.00	0.00	0.00
Current Ratio	0.08	0.08	0.10	0.10	0.10	0.08
Return on Equity (ROE)	-17.96%	-17.96%	-6.52%	-5.94%	-41.80%	-52.51%
Return on Assets (ROA)	-0.32%	-0.32%	-0.53%	-0.31%	-2.59%	-4.27%
Return on Capital Employed (ROCE)	-0.60%	-0.60%	-0.90%	-0.50%	-4.60%	-7.50%
Earnings Yield	-7.25%	-11.02%	-2.66%	-1.06%	-31.85%	-38.03%
FCF Yield	-0.05%	-0.07%	-1.98%	0.01%	-0.01%	0.36%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error